After finishing at $1.53 in the prior trading day, Ngm Biopharmaceuticals Inc (NASDAQ: NGM) closed at $1.54, up 0.65%. In other words, the price has increased by $+0.0100 from its previous closing price. On the day, 2351034 shares were traded. NGM stock price reached its highest trading level at $1.5500 during the session, while it also had its lowest trading level at $1.5200.
Ratios:
Our goal is to gain a better understanding of NGM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.92 and its Current Ratio is at 7.92. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On May 03, 2023, Citigroup started tracking the stock assigning a Buy rating and target price of $6.Citigroup initiated its Buy rating on May 03, 2023, with a $6 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 16 ’23 when COLUMN GROUP L P bought 5,840 shares for $0.62 per share. The transaction valued at 3,627 led to the insider holds 949,862 shares of the business.
COLUMN GROUP L P bought 5,840 shares of NGM for $3,627 on Nov 16 ’23. The Director now owns 949,862 shares after completing the transaction at $0.62 per share. On Nov 16 ’23, another insider, COLUMN GROUP L P, who serves as the Director of the company, bought 5,840 shares for $0.62 each. As a result, the insider paid 3,627 and bolstered with 949,862 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NGM now has a Market Capitalization of 127.70M and an Enterprise Value of -36.97M. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.68 while its Price-to-Book (P/B) ratio in mrq is 0.75. Its current Enterprise Value per Revenue stands at -1.65 whereas that against EBITDA is 0.23.
Stock Price History:
Over the past 52 weeks, NGM has reached a high of $4.69, while it has fallen to a 52-week low of $0.60. The 50-Day Moving Average of the stock is 1.4265, while the 200-Day Moving Average is calculated to be 1.7040.
Shares Statistics:
The stock has traded on average 1.27M shares per day over the past 3-months and 1.73M shares per day over the last 10 days, according to various share statistics. A total of 81.89M shares are outstanding, with a floating share count of 52.08M. Insiders hold about 37.04% of the company’s shares, while institutions hold 25.98% stake in the company. Shares short for NGM as of Feb 15, 2024 were 1.66M with a Short Ratio of 1.30, compared to 1.54M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.00% and a Short% of Float of 7.51%.
Earnings Estimates
Its stock is currently analyzed by 5 different market analysts. On average, analysts expect EPS of -$0.39 for the current quarter, with a high estimate of -$0.31 and a low estimate of -$0.66, while EPS last year was -$0.45. The consensus estimate for the next quarter is -$0.36, with high estimates of -$0.29 and low estimates of -$0.48.
Analysts are recommending an EPS of between -$1.7 and -$2.08 for the fiscal current year, implying an average EPS of -$1.79. EPS for the following year is -$1.2, with 5 analysts recommending between -$0.55 and -$1.63.
Revenue Estimates
A total of 5 analysts have provided revenue estimates for NGM’s current fiscal year. The highest revenue estimate was $6.25M, while the lowest revenue estimate was $4.25M, resulting in an average revenue estimate of $4.83M. In the same quarter a year ago, actual revenue was $55.33M, down -91.30% from the average estimate.
